New

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market

2021

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Scar Type (Hypertrophic and Keloid), Product Type (Laser Products, Topical Products, Injectables, Other Products), and End User (Hospitals, Clinics, and Homecare)

Publication Month: Oct 2021 | Report Code: TIPRE00025198 | No. of Pages: 90 | Category: Medical Device | Status: Published

Market Insights

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market to Grow at a CAGR of 9.5% to reach US$ 280.23 million from 2020 to 2027

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The hypertrophic and keloid scar treatment market in Middle East & Africa is expected to grow from US$ 148.07 million in 2020 to US$ 280.23 million by 2027; it is estimated to grow at a CAGR of 9.5% from 2020 to 2027.


UAE, Saudi Arabia

,

andSouth Africa are major economies in Middle East & Africa. Benefits of laser treatment is the major factor driving the growth of the Middle East & Africa hypertrophic and keloid scar treatment market. Technological advancements have led to the successful use of laser—especially 585 nm PDL, Q-switched 532 nm frequency-doubled Nd: YAG, and CO2 lasers, among other types—for treating hypertrophic and keloid scars. The laser treatment helps prevent scar formation after surgery; it reduces pain and itching and allows movement that is otherwise limited by the scar. The treatment is widely employed to treat hypertrophic and keloid scars caused by burns. According to the “Laser Management of Hypertrophic Burn Scars: a Comprehensive Review,” published in January 2020, burn-related injury follows more than 70% of hypertrophic scars. Similarly, according to the World Health Organization (WHO), burn is the major public health problem. Every year, ~265,000 deaths are registered due to scalds, electrical burns, and other burn forms. Moreover, 90% of the burn incidences are reported in low- and middle-income countries. As excessive collagen deposition leads to the generation of hypertrophic scars that lead to raised scars, laser treatment proves to be effective against them. Moreover, due to being a minimally invasive method, it ensures reduced scar thickness, pain, and postoperative recovery period. It also helps prevent the need for surgical excision and improves skin pigmentation, pliability, height, pruritus, texture, and heat sensitivity, among other skin conditions of the affected areas. Moreover, this treatment procedure proves to be cost-effective, especially for those opting for medical tourism. Owing to such advantages, there is high demand for the laser treatment curing hypertrophic and keloid scars, which is further anticipated to drive the market in Middle East & Africa.

Africa has reported 2,867,078 cases as of early January 2021. The number of COVID-19 cases has been increasing in South Africa (1,113,349), Iran (1,249,507), and Turkey (2,255,607). Economic uncertainties and ongoing conflicts are worsening the situation in the region. For instance, countries such as Syria, Libya, and Yemen are experiencing violent conflict and cannot complete any public health measures. Iran was in a deep economic collapse due to the US sanctions. Till October 2020, there was a higher incidence of COVID-19 in Egypt and the Republic of South Africa than in the general picture in Africa. However, the level is low as compared to the US, the UK, and Italy. The Middle East countries have registered a growth in the number of COVID-19 cases in the last few days, with the UAE registering 106,229 cases, Saudi Arabia reporting 339,267, and South Africa indicating 692,471 confirmed cases. However, the hypertrophic and keloid scar treatment market in this pandemic is declining due to the reduced demand for dermatology treatments. The countries are mainly focused on treating COVID-19 patients, and hence, the appointments for the hypertrophic and keloid scar treatment are postponed.

Get more information on this report :


Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Segmentation

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By Scar Type

  • Hypertrophic
  • Keloid

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By Product Type

  • Injectables
  • Topical
    • Gels
    • Silicone Sheets
    • Creams
    • Other
  • Laser
    • CO2
    • Pulse-Dyed
    • Other
  • Other

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By End User

  • Hospitals
  • Clinics
  • Homecare

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market, by Country

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Middle East & Africa Hypertrophic and Keloid Scar Treatment Market-Companies Mentioned

  • Alliance Pharma PLC
  • HRA Pharma
  • Mölnlycke Health Care AB.
  • Newmedical Technology Inc.
  • Perrigo Company plc
  • Smith & Nephew
  • Sonoma Pharmaceuticals, Inc
  • Suneva Medical

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By Scar Type

1.3.2 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By Product Type

1.3.3 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By End User

1.3.4 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – By Country

2. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East & Africa– PEST Analysis

4.3 Expert Opinion

5. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Benefits of Laser Treatment

5.1.2 Surge in Cases of Injuries

5.2 Market Restraints

5.2.1 Unavailability of Universal Treatment Due to Huge Costs, Side Effects, and Scanty Awareness

5.3 Market Opportunities

5.3.1 Tapping Market in Emerging Countries

5.4 Future Trends

5.4.1 Emerging Treatments Modalities

5.5 Impact Analysis

6. Hypertrophic and Keloid Scar Treatment Market – Middle East & Africa Analysis

6.1 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Revenue Forecast And Analysis

7. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– By Scar Type

7.1 Overview

7.2 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

7.3 Hypertrophic

7.3.1 Overview

7.3.2 Hypertrophic: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

7.4 Keloid

7.4.1 Overview

7.4.2 Keloid: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– By Product Type

8.1 Overview

8.2 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

8.3 Laser Products

8.3.1 Overview

8.3.2 Laser Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.1 CO2 Market

8.3.2.1.1 Overview

8.3.2.1.2 CO2 Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.2 Pulse-Dyed Market

8.3.2.2.1 Overview

8.3.2.2.2 Pulse-Dyed Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.3.2.3 Other Laser Products Market

8.3.2.3.1 Overview

8.3.2.3.2 Other Laser Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4 Topical Products

8.4.1 Overview

8.4.2 Topical Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.1 Creams Market

8.4.2.1.1 Overview

8.4.2.1.2 Creams: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.2 Gels Market

8.4.2.2.1 Overview

8.4.2.2.2 Gels: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.3 Silicone Sheets Market

8.4.2.3.1 Overview

8.4.2.3.2 Silicone Sheets: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.4.2.4 Other Topical Products Market

8.4.2.4.1 Overview

8.4.2.4.2 Others Topical Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.5 Injectables

8.5.1 Overview

8.5.2 Injectables: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

8.6 Other Products

8.6.1 Overview

8.6.2 Other Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– By End User

9.1 Overview

9.2 Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 Hospitals: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.4 Clinics

9.4.1 Overview

9.4.2 Clinics: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

10. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – Country Analysis

10.1 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market

10.1.1 Overview

10.1.2 Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

10.1.3 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.3.3 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Type, 2018–2027 (USD Million)

10.1.3.3.1 Saudi Arabia: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.3.3.2 Saudi Arabia: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.3.4 Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.4 UAE: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1 UAE: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2 UAE: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.4.3 UAE: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.4.3.1 UAE: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.4.3.2 UAE: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.4.4 UAE: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.5 South Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1 South Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2 South Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.5.3 South Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.5.3.1 South Africa: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.5.3.2 South Africa: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.5.4 South Africa: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

10.1.6 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type, 2018–2027 (USD Million)

10.1.6.3 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type, 2018–2027 (USD Million)

10.1.6.3.1 Rest of Middle East & Africa: Laser Products Market, by Type, 2018–2027 (USD Million)

10.1.6.3.2 Rest of Middle East & Africa: Topical Products Market, by Type, 2018–2027 (USD Million)

10.1.6.4 Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by End User, 2018–2027 (USD Million)

11. Impact Of COVID-19 Pandemic On Middle East & Africa Hypertrophic and Keloid Scar Treatment Market

11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. COMPANY PROFILES

13.1 Alliance Pharma PLC

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Mölnlycke Health Care AB.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Smith & Nephew

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Newmedical Technology Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5.5 Sonoma Pharmaceuticals, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Suneva Medical

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 HRA Pharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Perrigo Company plc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (US$ Million)

Table 2. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 3. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4. Saudi Arabia: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 5. Saudi Arabia: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7. UAE: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 8. UAE: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 9. UAE: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10. UAE: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 11. UAE: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 12. South Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 13. South Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14. South Africa: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15. South Africa: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16. South Africa: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 17. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Scar Type – Revenue and Forecast to 2027 (USD Million)

Table 18. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 19. Rest of Middle East & Africa: Laser Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20. Rest of Middle East & Africa: Topical Products Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 22. Organic Developments Done By Companies

Table 23. Inorganic Developments Done By Companies

Table 24. Glossary of Terms, Hypertrophic and Keloid Scar Treatment Market

LIST OF FIGURES

Figure 1. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Segmentation

Figure 2. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market, By Country

Figure 3. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Overview

Figure 4. Hypertrophic Segment Held Largest Share of Scar Type Segment In Middle East & Africa Hypertrophic and Keloid Scar Treatment Market

Figure 5. South Africa Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Middle East & Africa PEST Analysis

Figure 7. Expert Opinion

Figure 8. Hypertrophic and Keloid Scar Treatment Market Impact Analysis of Drivers and Restraint

Figure 9. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market – Revenue Forecast and Analysis – 2018- 2027

Figure 10. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Share, by Scar Type, 2019 and 2027 (%)

Figure 11. Hypertrophic: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 12. Keloid: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 13. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Share, by Product Type, 2019 and 2027 (%)

Figure 14. Laser Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 15. CO2 Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 16. Pulse-Dyed Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 17. Other Laser Products Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 18. Topical Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 19. Creams Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 20. Gels Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 21. Silicone Sheets Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 22. Other Topical Products Market: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 23. Injectables: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 24. Other Products: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 25. Middle East & Africa Hypertrophic and Keloid Scar Treatment Market Share, by End User, 2019 and 2027 (%)

Figure 26. Hospitals: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 27. Clinics: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 28. Homecare: Middle East & Africa Hypertrophic and Keloid Scar Treatment Market– Revenue and Forecast to 2027 (USD Million)

Figure 29. Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Key Country – Revenue (2019) (USD Million)

Figure 30. Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market, by Country, 2019 & 2027 (%)

Figure 31. Saudi Arabia: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 32. UAE: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 33. South Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. Rest of Middle East & Africa: Hypertrophic and Keloid Scar Treatment Market – Revenue and Forecast to 2027 (USD Million)

Figure 35. Impact Of COVID-19 Pandemic In Middle East and Africa Market

  1. Alliance Pharma PLC
  2. HRA Pharma
  3. Mölnlycke Health Care AB.
  4. Newmedical Technology Inc.
  5. Perrigo Company plc
  6. Smith & Nephew
  7. Sonoma Pharmaceuticals, Inc
  8. Suneva Medical
  • To understand the Middle East & Africa hypertrophic and keloid scar treatment market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East & Africa hypertrophic and keloid scar treatment market
  • Efficiently plan M&A and partnership deals in Middle East & Africa hypertrophic and keloid scar treatment market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East & Africa hypertrophic and keloid scar treatment market
  • Obtain market revenue forecast for market by various segments from 2020-2027 in Middle East & Africa region.
TIPRE00025198
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.